Send the following on WhatsApp
Continue to ChatTHE CLINICAL EFFICACY OF EPOETIN ALFA AND DARBEPOETIN ALFA IN PATIENTS WITH LOW-RISK OR INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROME: RETROSPECTIVE MULTI-CENTER REAL-LIFE STUDY - https://avesis.kocaeli.edu.tr/yayin/97de4046-f76a-4deb-9432-65671f0e6f78/the-clinical-efficacy-of-epoetin-alfa-and-darbepoetin-alfa-in-patients-with-low-risk-or-intermediate-1-risk-myelodysplastic-syndrome-retrospective-multi-center-real-life-study